DEEP BRAIN STIMULATION DEVICES MARKET FOR PARKINSON’S DISEASE ANALYSIS

Deep Brain Stimulation Devices Market for Parkinson’s DiseaseSize and Trends

Figure 1. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Value (US$ Mn), by Region, 2020

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Drivers

Increasing prevalence of Parkinson’s disease is expected to propel growth of the global deep brain stimulation devices market for Parkinson’s disease over the forecast period. For instance, according to the study, ‘Prevalence of Parkinson’s disease (PD) across North America”, published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030.   

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Figure 2. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Share, By Product, 2020

Key Takeaways of the Graph:

• Among product, the dual-channel held dominant position in the market and accounted for 31.8% share in the global deep brain stimulation devices market for Parkinson’s disease in 2020. The segment is expected to reach US$ 2,001.2 million in 2028.
• The growth in the segment can be attributed to new studies focused on dual channel deep brain stimulation system. For instance, based on a 2020 research study published in the Korean Movement Disorder Society compared the single and dual channel deep brain stimulation system. In the study, it was concluded that dual channel systems such as SceneRay, G102 and G102R enabled increased access to neurologists for evaluating and treating Parkinson’s disease.

Market Trends

Deep brain stimulation devices for Parkinson’s disease are vulnerable to electromagnetic interference. In May 2018, a study published in the Journal of Neurosurgery, researchers noted that deep brain stimulation devices used to treat neurological movement disorders such as Parkinson’s disease, are vulnerable to strong electromagnetic fields that are created by other electrical devices.

R&D in deep brain stimulation is expected to boost growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in June 2020, the study, “The structural connectivity of subthalamic deep brain stimulation correlates with impulsivity in Parkinson’s,” published in the journal Brain, reported that distinct connections between nerve cells in the brain may explain the reason behind Parkinson’s disease patients developing impulsivity and behavioral problems after deep brain stimulation therapy.